Osimertinib Completed Phase 1 Trials for Healthy Volunteers Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01951599To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.
NCT02096679Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD9291 in Volunteers